References
1. Ubago JL, Figueroa A, Colman T, Ochoteco A, Duran CG.Hemodynamic Factors That Affect Calculated Orifice Areas in the Mitral
Hancock Xenograft Valve. Circulation. 1980 Feb;61(2):388-94.
2. Yoon S-H, Whisenant BK, Bleiziffer S, et al. Outcomes of
transcatheter mitral valve replacement for degenerated bioprostheses,
failed annuloplasty rings, and mitral annular calcification. Eur Heart J
2019;40:441–451.
3. Russell HM, Guerrero ME, Salinger MH, et al. Open atrial
transcatheter mitral valve replacement in patients with mitral annular
calcification. J Am Coll Cardiol 2018;72:1437–1448.
4. Babaliaros VC, Greenbaum AB, Khan JM, et al. Intentional
percutaneous laceration of the anterior mitral leaflet to prevent out-
flow obstruction during transcatheter mitral valve replacement:
first-in-human experience. JACC Cardiovasc Interv 2017;10:798–809.
5. Whisenant B, Kapadia SR, Eleid MF, et al. One-Year Outcomes
of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve.
JAMA Cardiol. 2020. doi:10.1001/jamacardio.2020.2974.
6. Kiefer P, Noack T, Seeburger J, et al. Transapical Mitral
Valve Implantation for Native Mitral Valve Stenosis Using a
Balloon-Expandable Prosthesis. Ann Thorac Surg. 2017
Dec;104(6):2030-2036.
7. Flameng W, Rega F, Vercalsteren M, Herijgers P, Meuris B.Antimineralization Treatment and Patient-Prosthesis Mismatch Are Major
Determinants of the Onset and Incidence of Structural Valve Degeneration
in Bioprosthetic Heart Valves. J Thorac Cardiovasc Surg. 2014
Apr;147(4):1219-24.